Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Impact of Earlier, Later BMI on Multiple Myeloma Risk
Cancer Epidemiol Biomarkers Prev; ePub 2017 Feb 21; Birmann, et al
Earlier and later adult BMI may increase the risk for multiple myeloma, according to a pooled analysis involving nearly 12,000 individuals.
Investigators conducted multivariable logistic regression analysis of usual adult anthropometric measures in participants with multiple myeloma (n= 2,318) and controls (n=9,609), and of young adult BMI (age 25 or 30 years) in a subset with multiple myeloma (n=1,164) and controls (n=3,629). Among the results:
- Multiple myeloma risk was positively linked with usual adult BMI; risk increased 9% per 5-kg/m2 increase in BMI.
- Young adult BMI was also positively associated with MM; risk increased 20% per 5-kg/m2 increase in BMI.
- People who were overweight or obese at both younger age and as adults had a significantly higher risk of developing multiple myeloma than those who were not overweight or obese.
- This was not the case for those overweight or obese at only 1 time period.
Birmann B, Andreotti G, De Roos A, et al. Young adult and usual adult body mass index and multiple myeloma risk: A pooled analysis in the International Multiple Myeloma Consortium (IMMC). [Published online ahead of print February 21, 2017]. Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-16-0762-T.
This Week's Must Reads
Must Reads in Hematologic Malignancies
Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10
Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al
These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al
Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al
The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al